Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|March 26, 2011
Critical appraisal of once-weekly formulation of exenatide in the control of type 2 diabetes mellitusJason Seewoodhary, Leanne Griffin, Stephen C Bain
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|July 24, 2009
Treatment of type 2 diabetes mellitus with orally administered agents: advances in combination therapyStephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 17, 2014
The clinical development program of lixisenatide: a once-daily glucagon-like Peptide-1 receptor agonistStephen C Bain
Endocrinology and Metabolism (Seoul, Korea)|February 6, 2023
Glucagon-Like Peptide 1 Therapy: From Discovery to Type 2 Diabetes and BeyondAdie Viljoen, Stephen C Bain
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 16, 2020
The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical TrialsThinzar Min, Stephen C Bain
Expert Opinion on Emerging Drugs|March 10, 2023
Emerging drugs for the treatment of type 1 diabetes mellitus: a review of phase 2 clinical trialsThinzar Min, Stephen C Bain
Drug Design, Development and Therapy|September 17, 2013
A review of sitagliptin with special emphasis on its use in moderate to severe renal impairmentVinay S Eligar, Stephen C Bain
Expert Opinion on Drug Safety|August 11, 2007
Safety and adverse effects associated with GLP-1 analoguesJeffrey W Stephens, Stephen C Bain
Expert Opinion on Drug Safety|December 22, 2006
Insulin glulisine: efficacy and safety compared with other rapid-acting insulin analoguesAli D Kamal, Stephen C Bain
Pageof 13